These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 23234586

  • 1. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
    Roke Y, Buitelaar JK, Boot AM, Tenback D, van Harten PN.
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
    [Abstract] [Full Text] [Related]

  • 2. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y, van Harten PN, Franke B, Galesloot TE, Boot AM, Buitelaar JK.
    Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.
    Roke Y, van Harten PN, Buitelaar JK, Tenback DE, Quekel LG, de Rijke YB, Boot AM.
    Eur J Endocrinol; 2012 Dec; 167(6):855-63. PubMed ID: 23011870
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
    Montalvo I, Ortega L, López X, Solé M, Monseny R, Franch J, Vilella E, Labad J.
    Int Clin Psychopharmacol; 2013 Jan; 28(1):46-9. PubMed ID: 23232756
    [Abstract] [Full Text] [Related]

  • 7. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y, van Harten PN, Boot AM, Buitelaar JK.
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [Abstract] [Full Text] [Related]

  • 8. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
    Hellings JA, Zarcone JR, Valdovinos MG, Reese RM, Gaughan E, Schroeder SR.
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX, Su YA, Bian QT, Wei LH, Zhang RZ, Liu YH, Correll C, Soares JC, Yang FD, Wang SL, Zhang XY.
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [Abstract] [Full Text] [Related]

  • 10. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
    Haas M, Karcher K, Pandina GJ.
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
    [Abstract] [Full Text] [Related]

  • 11. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T, Bonsack C.
    Encephale; 2006 Aug; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [Abstract] [Full Text] [Related]

  • 12. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
    Park YM, Lee SH, Lee BH, Lee KY, Lee KS, Kang SG, Lee HY, Kim W.
    Psychiatry Res; 2016 May 30; 239():184-9. PubMed ID: 27010188
    [Abstract] [Full Text] [Related]

  • 13. Prolactin Levels During Long-Term Risperidone Treatment in Children and Adolescents: a reanalysis of data.
    Findling RL, Daneman D.
    J Clin Psychiatry; 2016 Feb 30; 77(2):e155-70. PubMed ID: 26930529
    [No Abstract] [Full Text] [Related]

  • 14. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M, Bares M, Horacek J, Mohr P.
    Neuro Endocrinol Lett; 2006 Dec 30; 27(6):803-6. PubMed ID: 17187006
    [Abstract] [Full Text] [Related]

  • 15. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK, Huang YS, Ree SC, Hsiao CC.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1495-9. PubMed ID: 20732372
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr 01; 28 Suppl 2():55-68. PubMed ID: 12650681
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L, Matera E, Craig F, Petruzzelli MG, Palmieri VO, Pastore A, Margari F.
    Int Clin Psychopharmacol; 2013 Jul 01; 28(4):177-83. PubMed ID: 23689836
    [Abstract] [Full Text] [Related]

  • 18. Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
    Calarge CA, Miller del D.
    J Child Adolesc Psychopharmacol; 2011 Apr 01; 21(2):163-9. PubMed ID: 21486167
    [Abstract] [Full Text] [Related]

  • 19. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA, Ellingrod VL, Acion L, Miller DD, Moline J, Tansey MJ, Schlechte JA.
    Pharmacogenet Genomics; 2009 May 01; 19(5):373-82. PubMed ID: 19339912
    [Abstract] [Full Text] [Related]

  • 20. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
    Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA.
    Psychoneuroendocrinology; 2006 Jun 01; 31(5):577-88. PubMed ID: 16488084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.